Oryzon Genomics SA Asset Resilience Ratio

Latest as of December 2025: 0.01%

Oryzon Genomics SA asset resilience ratio. Oryzon Genomics SA (ORY) has an Asset Resilience Ratio of 0.01% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Oryzon Genomics SA to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€14.58K

≈ $17.05K USD Cash + Short-term Investments

Total Assets

€144.52 Million

≈ $168.96 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Oryzon Genomics SA (2011–2025)

Asset resilience ratio of Oryzon Genomics SA from 2011 to 2025. This chart shows how Oryzon Genomics SA's Asset Resilience Ratio has changed over time. Read Oryzon Genomics SA total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Oryzon Genomics SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Oryzon Genomics SA.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€14.58K	0.01%
Total Liquid Assets	€14.58K	0.01%

Asset Resilience Insights

Limited Liquidity: Oryzon Genomics SA maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Oryzon Genomics SA Industry Peers by Asset Resilience Ratio

Compare Oryzon Genomics SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Immunovant Inc NASDAQ:IMVT	Biotechnology	98.50%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%

Oryzon Genomics SA Asset Resilience Ratio by Year (2011–2025)

Oryzon Genomics SA asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Oryzon Genomics SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.01%	€14.58K ≈ $17.05K	€144.52 Million ≈ $168.96 Million	--
2020-12-31	0.00%	€0.00 ≈ $0.00	€94.11 Million ≈ $110.02 Million	--
2019-12-31	0.18%	€141.56K ≈ $165.49K	€80.09 Million ≈ $93.64 Million	-0.03pp
2018-12-31	0.21%	€141.56K ≈ $165.49K	€67.45 Million ≈ $78.86 Million	-0.14pp
2017-12-31	0.35%	€213.18K ≈ $249.23K	€61.04 Million ≈ $71.37 Million	-10.19pp
2016-12-31	10.54%	€5.24 Million ≈ $6.13 Million	€49.74 Million ≈ $58.16 Million	+4.99pp
2015-12-31	5.55%	€2.26 Million ≈ $2.64 Million	€40.73 Million ≈ $47.62 Million	-16.10pp
2014-12-31	21.65%	€5.64 Million ≈ $6.60 Million	€26.06 Million ≈ $30.46 Million	+21.16pp
2013-12-31	0.49%	€142.00K ≈ $166.01K	€28.76 Million ≈ $33.63 Million	-1.26pp
2012-12-31	1.76%	€506.00K ≈ $591.57K	€28.78 Million ≈ $33.65 Million	-6.15pp
2011-12-31	7.91%	€2.31 Million ≈ $2.70 Million	€29.21 Million ≈ $34.15 Million	--

pp = percentage points

About Oryzon Genomics SA

MC:ORY Spain Biotechnology

Market Cap

$211.33 Million

€180.76 Million EUR

Market Cap Rank

#16083 Global

#107 in Spain

Share Price

€2.33

Change (1 day)

-0.93%

52-Week Range

€2.33 - €3.40

All Time High

€5.14